On 3/27/24, NovoCure Ltd (NASDAQ: NVCR) stock enjoyed a major increase of 12.0%, closing at $14.64. Moreover, trading volume in this advance was exceptionally high at 856% of normal. Relative to the market the stock has been extremely weak over the last nine months but has risen 8.1% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, NVCR is expected to continue to be Value Creation neutral.
NovoCure has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing highly consistent signals. NovoCure has a very low Appreciation Score of 9 and a very low Power Rating of 5, producing the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment